Diabetes

Top news of the day from across the health care landscape.

The number of patients who have from diabetes is expected to almost double from 285 million to 438 million people by 2030 due to obesity trends.

SmartMat offers early protection against nontraumatic plantar foot ulcers foot ulcers before presentation.

Amlexanox may alter genes that improve blood glucose control in patients with type 2 diabetes.

Top news of the day from across the health care landscape.

Patients with obstructive sleep apnea and type 2 diabetes have an increased risk of retinopathy.

Children diagnosed with diabetic ketoacidosis and type 1 diabetes may have higher HbA1C levels.

Pharmacists’ roles are expanding from traditional retail settings, allowing them to be more involved in patient care than ever before.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Eradicating hepatitis C virus with antiviral drugs found to improve comorbid conditions.

Diabetes' propensity to cause metabolic derangement is directly responsible for a looming epidemic of diabetic kidney disease (DKD). And left unchecked, DKD can progress to end-stage kidney disease (ESKD).

How can we reduce the burden of type 1 diabetes? Automated insulin delivery systems could be the answer.

A diabetes wearable device can measure cortisol, glucose, and interleukin-6 in sweat to track disease progession.

Dutasteride (Avodart) increases blood sugar, A1C, and blood lipids.

Liraglutide is an injectable prescription drug that may improve glucose in adults with type 2 diabetes.

Prebiotics seen to reduce weight gain among pediatric patients who were overweight or obese.

Patients with diabetes could benefit greatly from technological advances.

Approximately 72% of Medicare beneficiaries have at least 2 chronic medical conditions (most often diabetes, heart disease, and asthma/COPD), and roughly 40% have 4 or more.

Top articles of the week from The American Journal of Pharmacy Benefits.

Alternative treatment options to control blood glucose level in patients with type 2 diabetes show promise.

Novel treatment may prevent patients with type 1 diabetes from developing end-stage renal disease.

A dose of insulin 3 hours after eating may prevent blood vessel damage among patients with type 1 diabetes.

Top news of the day from across the health care landscape.

Patients with type 2 diabetes who do not take insulin may not require fingerstick testing.